Atlas Trials

Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin

Clinical trial NCT04431141 · COMPLETED

Trial details

NCT number
NCT04431141
Sponsor
Handok Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2020-09-15
Primary completion
2020-11-16
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.